SLMO2-ATP5E: A Potential Drug Target and Biomarker (G100533975)

Target Name: SLMO2-ATP5E

NCBI ID: G100533975

SLMO2-ATP5E

Other Name(s): SLMO2-ATP5E readthrough | SLMO2-ATP5E variant 1 | SLMO2-ATP5E readthrough, transcript variant 1

SLMO2-ATP5E: A Potential Drug Target and Biomarker

SLMO2-ATP5E is a protein that is expressed in the brain and is involved in the regulation of cell survival and proliferation. The SLMO2 gene has been implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The ATP5E gene has also been associated with various diseases, including heart disease and diabetes.

The potential drug target for SLMO2-ATP5E is related to its role in cell survival and proliferation.SLMO2 has been shown to regulate the activity of the transcription factor, p53, which plays a crucial role in cell survival and proliferation. The p53 protein is a well-established drug target for various diseases, including cancer, and has been shown to be involved in the regulation of many diseases, including Alzheimer's disease.

SLMO2-ATP5E has also been shown to interact with the protein, p16INK4a.p16INK4a is a negative regulator of the p53 protein and has been shown to play a role in the regulation of cell survival and proliferation. The interaction between SLMO2-ATP5E and p16INK4a suggests that SLMO2-ATP5E may be a potential drug target for diseases that are characterized by the over-expression or dysfunction of the p53 protein.

The potential drug target for SLMO2-ATP5E is also related to its role in the regulation of cellular metabolism.SLMO2 has been shown to be involved in the regulation of cellular metabolism and has been shown to play a role in the regulation of the levels of various cellular metabolites, including glucose, insulin, and glutamate. The regulation of cellular metabolism is a crucial aspect of cellular function and is involved in the development and progression of many diseases, including Alzheimer's disease.

The potential drug target for SLMO2-ATP5E is related to its role in the regulation of cellular stress response.SLMO2 has been shown to be involved in the regulation of cellular stress response and has been shown to play a role in the regulation of cellular stress-induced signaling pathways. The regulation of cellular stress response is a crucial aspect of cellular function and is involved in the development and progression of many diseases, including multiple sclerosis.

The potential drug target for SLMO2-ATP5E is related to its role in the regulation of cellular apoptosis.SLMO2 has been shown to be involved in the regulation of cellular apoptosis and has been shown to play a role in the regulation of apoptosis-induced signaling pathways. The regulation of cellular apoptosis is a crucial aspect of cellular function and is involved in the development and progression of many diseases, including Alzheimer's disease.

In conclusion, SLMO2-ATP5E is a protein that is involved in the regulation of cell survival and proliferation, cellular metabolism, stress response, and apoptosis. The potential drug target for SLMO2-ATP5E is related to its role in the regulation of these processes and suggests that it may be a useful target for the development of new drugs for various neurological and other diseases. Further research is needed to determine the exact mechanism of action of SLMO2-ATP5E and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: SLMO2-ATP5E Readthrough

The "SLMO2-ATP5E Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLMO2-ATP5E comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets